Mitochondria: Determinants of stem cell fate?

Stem Cells and Development

Volumn 18, Issue 6, 2009, Pages 803-806

  Parker, Graham C ^a,b   Acsadi, Gyula ^a   Brenner, Carol A ^a  

^a WAYNE STATE UNIVERSITY   (United States)

^b WAYNE STATE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CELL DIFFERENTIATION; CELL FATE; CELL PROLIFERATION; CELL SURVIVAL; CELL VIABILITY; EMBRYONIC STEM CELL; HUMAN; MITOCHONDRION; NONHUMAN; PLURIPOTENT STEM CELL; PRIORITY JOURNAL; REVIEW; SOMATIC STEM CELL; STEM CELL;

ANIMALS; CELL LINEAGE; EMBRYONIC STEM CELLS; HUMANS; MITOCHONDRIA; PLURIPOTENT STEM CELLS; STEM CELLS;

EID: 67651119928     PISSN: 15473287     EISSN: None     Source Type: Journal    
DOI: 10.1089/scd.2009.1806.edi     Document Type: Review

References (55)

1. Barja G and A Herrero. (2000). Oxidative damage to mitochon-drial DNA is inversely related to maximum life span in the heart and brain of mammals. FASEB J 14:312-318.
2. De Flora S and A Izzotti. (2008). Modulation of genomic and postgenomic alterations in noncancer diseases and critical periods of life. Mutat Res. [Epub ahead of print]
3. Flores I, A Canela, E Vera, A Tejera, G Cotsarelis and MA Blasco. (2008). The longest telomeres: a general signature of adult stem cell compartments. Genes Dev 22:654-667.
4. Arai F and T Suda. (2007). Maintenance of quiescent hemato-poietic stem cells in the osteoblastic niche. Ann N Y Acad Sci 1106:41-53.
5. Lyu BN, SB Ismailov, B Ismailov and MB Lyu. (2008). Mitochondrial concept of leukemogenesis: key role of oxygen-peroxide effects. Theor Biol Med Model 5:23.
6. Tothova Z, R Kollipara, BJ Huntly, BH Lee, DH Castrillon, DE Cullen, EP McDowell, S Lazo-Kallanian, IR Williams, C Sears, SA Armstrong, E Passegue, RA DePinho and DG Gilliland. (2007). FoxOs are critical mediators of hematopoietic stem cell resistance to physiologic oxidative stress. Cell 128:325-339.
7. Ito K, A Hirao, F Arai, S Matsuoka, K Takubo, I Hamaguchi, K Nomiyama, K Hosokawa, K Sakurada, N Nakagata, Y Ikeda, TW Mak and T Suda. (2004). Regulation of oxidative stress by ATM is required for self-renewal of haematopoietic stem cells. Nature 431:997-1002.
8. Du W, Z Adam, R Rani, X Zhang and Q Pang. (2008). Oxidative stress in Fanconi anemia hematopoiesis and disease progression. Antioxid Redox Signal 10:1909-1921.
9. Haneline LS. (2008). Redox regulation of stem and progenitor cells. Antioxid Redox Signal 10:1849-1852.
10. Ghaffari S. (2008). Oxidative stress in the regulation of normal and neoplastic hematopoiesis. Antioxid Redox Signal 10:1923-1940.
11. Naka K, T Muraguchi, T Hoshii and A Hirao. (2008). Regulation of reactive oxygen species and genomic stability in hematopoi-etic stem cells. Antioxid Redox Signal 10:1883-1894.
12. Ohshima M, TS Li, M Kubo, SL Qin and K Hamano. (2009). Antioxidant therapy attenuates diabetes-related impairment of bone marrow stem cells. Circ J 73:162-166.
13. Lonergan T, B Bavister and C Brenner. (2007). Mitochondria in stem cells. Mitochondrion 7:289-296.
14. Lonergan T, C Brenner and B Bavister. (2006). Differentiation-related changes in mitochondrial properties as indicators of stem cell competence. J Cell Physiol 208:149-153.
15. Urish KL, JB Vella, M Okada, BM Deasy, K Tobita, BB Keller, B Cao, JD Piganelli and J Huard. (2009). Antioxidant levels represent a major determinant in the regenerative capacity of muscle stem cells. Mol Biol Cell 20:509-520.
16. Diehn M, RW Cho, NA Lobo, T Kalisky, MJ Dorie, AN Kulp, D Qian, JS Lam, LE Ailles, M Wong, B Joshua, MJ Kaplan, I Wapnir, FM Dirbas, G Somlo, C Garberoglio, B Paz, J Shen, SK Lau, SR Quake, JM Brown, IL Weissman and MF Clarke. (2009). Association of reactive oxygen species levels and radioresis-tance in cancer stem cells. Nature 458:780-783.
17. Tsatmali M, EC Walcott and KL Crossin. (2005). Newborn neurons acquire high levels of reactive oxygen species and increased mitochondrial proteins upon differentiation from progenitors. Brain Res 1040:137-150.
18. Abrahan CE, MF Insua, LE Politi, OL German and NP Rotstein. (2009). Oxidative stress promotes proliferation and dedifferentiation of retina glial cells in vitro. J Neurosci Res 87: 964-977.
19. Shy ME, JR Lupski, PF Chance, CJ Klein and P Dyck. (2005). The hereditary motor and sensory neuropathies: an overview of the clinical, genetic, electrophysiologic and pathologic features. In: Peripheral Neuropathy. Dyck PJ, ed. W.B. Saunders, Philadelphia, pp 1623-1658.
20. Lovelace R. (1990). Hereditary induced peripheral neuropathies. Clin Podiatr Med Surg 7:37-50.
21. Harding AE and PK Thomas. (1980). The clinical features of hereditary motor and sensory neuropathy types I and II. Brain 103:259-280.
22. Sevilla T, A Cuesta, MJ Chumillas, F Mayordomo, L Pedrola, F Palau and JJ Vilchez. (2003). Clinical, electrophysiological and morphological f ndings of Charcot-Marie-Tooth neuropathy with vocal cord palsy and mutations in the GDAP1 gene. Brain 126:2023-2033.
23. Lawson VH, BV Graham and KM Flanigan. (2005). Clinical and electrophysiologic features of CMT2A with mutations in the mitofusin 2 gene. Neurology 65:197-204.
24. Neusch C, J Senderek, T Eggermann, E Elolff, M Bahr and C Schneider-Gold. (2007). Mitofusin 2 gene mutation (R94Q) causing severe early-onset axonal polyneuropathy (CMT2A). Eur J Neurol 14:575-577.
25. Chen H, JM McCaffery and DC Chan. (2007). Mitochondrial fusion protects against neurodegeneration in the cerebellum. Cell 130:548-562.
26. de Brito OM and L Scorrano. (2009). Mitofusin-2 regulates mito-chondrial and endoplasmic reticulum morphology and tethering: The role of Ras. Mitochondrion 9:222-226.
27. Baloh RH, RE Schmidt, A Pestronk and J Milbrandt. (2007). Altered axonal mitochondrial transport in the pathogenesis of Charcot-Marie-Tooth disease from mitofusin 2 mutations. J Neurosci 27:422-430.
28. Griff n EE, SA Detmer and DC Chan. (2006). Molecular mechanism of mitochondrial membrane fusion. Biochim Biophys Acta 1763:482-489.
29. Amiott EA, P Lott, J Soto, PB Kang, JM McCaffery, S DiMauro, ED Abel, KM Flanigan, VH Lawson and JM Shaw. (2008). Mitochondrial fusion and function in Charcot-Marie-Tooth type 2A patient f broblasts with mitofusin 2 mutations. Exp Neurol 211:115-127.
30. Knott AB and E Bossy-Wetzel. (2008). Impairing the mitochon-drial f ssion and fusion balance: a new mechanism of neurode-generation. Ann N Y Acad Sci 1147:283-292.
31. Knott AB, G Perkins, R Schwarzenbacher and E Bossy-Wetzel. (2008). Mitochondrial fragmentation in neurodegeneration. Nat Rev Neurosci 9:505-518.
32. Murayama S, TW Bouldin and K Suzuki. (1991). Immunocy-tochemical and ultrastructural studies of Werdnig-Hoffmann disease. Acta Neuropathol (Berl) 81:408-417.
33. Talbot K and KE Davies. (2001). Spinal muscular atrophy. Semin Neurolgy 21:189-197.
34. Brzustowicz LM, T Lehner, LH Castilla, GK Penchaszadeh, KC Wilhelmsen, R Daniels, KE Davies, M Leppert, F Ziter, D Wood, V Dubowitz, K Zerres, I Hausmanowa-Petrusewicz, J Ott, TL Munsat and TC Gilliam. (1990). Genetic mapping of chronic childhood-onset spinal muscular atrophy to chromosome 5q11.2-13.3. Nature 344:540-541.
35. Lefebvre S, L Burglen, S Reboullet, O Clermont, P Burlet, L Viollet, B Benichou, C Cruaud, P Millasseau, M Zeviani, D Le Paslier, J Frézal, D Cohen, J Weissenbach, A Munnich and J Melki. (1995). Identif cation and characterization of a spinal muscular atrophy-determining gene. Cell 80:155-165.
36. Fan L and LR Simard. (2002). Survival motor neuron (SMN) protein: role in neurite outgrowth and neuromuscular maturation during neuronal differentiation and development. Hum Mol Genet 11:1605-1614.
37. Fischer U, Q Liu and G Dreyfuss. (1997). The SMN-SIP1 complex has an essential role in spliceosomal snRNP biogenesis. Cell 90:1023-1029.
38. Francis JW, AW Sandrock, PG Bhide, JP Vonsattel and RH Brown, Jr. (1998). Heterogeneity of subcellular localization and electrophoretic mobility of survival motor neuron (SMN) protein in mammalian neural cells and tissues. Proc Natl Acad Sci USA 95:6492-6497.
39. Rossoll W, S Jablonka, C Andreassi, AK Kroning, K Karle, UR Monani and M Sendtner. (2003). Smn, the spinal muscular atrophy-determining gene product, modulates axon growth and localization of beta-actin mRNA in growth cones of motoneu-rons. J Cell Biol 163:801-812.
40. Parker GC, X Li, RA Anguelov, G Toth, A Cristescu and G Acsadi. (2008). Survival motor neuron protein regulates apop-tosis in an in vitro model of spinal muscular atrophy. Neurotox Res 13:39-48.
41. Acsadi G, I Lee, X Li, M Khaidakov, A Pecinova, GC Parker and M Hüttemann. (2009). Mitochondrial dysfunction in a neural cell model of spinal muscular atrophy. J Neurosci Res. [Epub ahead of print]
42. Voccoli V and L Colombaioni. (2009). Mitochondrial remodeling in differentiating neuroblasts. Brain Res 1252:15-29.
43. Saretzki G, L Armstrong, A Leake, M Lako and T von Zglinicki. (2004). Stress defense in murine embryonic stem cells is superior to that of various differentiated murine cells. Stem Cells 22:962-971.
44. Lonergan T, A Harvey, J Zhao, B Bavister and C Brenner. (2008). Active mitochondria are present in mouse and monkey embryonic stem cells. Reprod Fertil Dev. 20:223.
45. St John JC, A Amaral, E Bowles, JF Oliveira, R Lloyd, M Freitas, HL Gray, CS Navara, G Oliveira, GP Schatten, E Spikings and J Ramalho-Santos. (2006). The analysis of mitochondria and mitochondrial DNA in human embryonic stem cells. Methods Mol Biol 331:347-374.
46. Facucho-Oliveira JM, J Alderson, EC Spikings, S Egginton and JC St John. (2007). Mitochondrial DNA replication during differentiation of murine embryonic stem cells. J Cell Sci 120:4025-4034.
47. Spikings EC, J Alderson and JC John. (2007). Regulated mito-chondrial DNA replication during oocyte maturation is essential for successful porcine embryonic development. Biol Reprod 76:327-335.
48. Schieke SM, M Ma, L Cao, JP McCoy, Jr., C Liu, NF Hensel, AJ Barrett, M Boehm and T Finkel. (2008). Mitochondrial metabolism modulates differentiation and teratoma formation capacity in mouse embryonic stem cells. J Biol Chem 283:28506-28512.
49. Park IH, N Arora, H Huo, N Maherali, T Ahfeldt, A Shimamura, MW Lensch, C Cowan, K Hochedlinger and GQ Daley. (2008). Disease-specif c induced pluripotent stem cells. Cell 134:877-886.
50. Ebert AD, J Yu, FF Rose, Jr., VB Mattis, CL Lorson, JA Thomson and CN Svendsen. (2009). Induced pluripotent stem cells from a spinal muscular atrophy patient. Nature 457:277-280.
51. Dimos JT, KT Rodolfa, KK Niakan, LM Weisenthal, H Mitsumoto, W Chung, GF Croft, G Saphier, R Leibel, R Goland, H Wichterle, CE Henderson and K Eggan. (2008). Induced pluripotent stem cells generated from patients with ALS can be differentiated into motor neurons. Science 321:1218-1221.
52. Burton A. (2006). mtDNA deletions associated with ageing and PD. Lancet Neurol 5:477.
53. Jendrach M, S Mai, S Pohl, M Voth and J Bereiter-Hahn. (2008). Short- and long-term alterations of mitochondrial morphology, dynamics and mtDNA after transient oxidative stress. Mitochondrion 8:293-304.
54. Aliyev A, SG Chen, D Seyidova, MA Smith, G Perry, J de la Torre and G Aliev. (2005). Mitochondria DNA deletions in atherosclerotic hypoperfused brain microvessels as a primary target for the development of Alzheimer's disease. J Neurol Sci 229-230:285-292.
55. Oberdoerffer P, S Michan, M McVay, R Mostoslavsky, J Vann, SK Park, A Hartlerode, J Stegmuller, A Hafner, P Loerch, SM Wright, KD Mills, A Bonni, BA Yankner, R Scully, TA Prolla, FW Alt and DA Sinclair. (2008). SIRT1 redistribution on chromatin promotes genomic stability but alters gene expression during aging. Cell 135:907-918.